Skip to content

Proprioceptive Neuromuscular Facilitation Protocol for adults with Traumatic Upper Plexus Injury

Development of a protocol using Proprioceptive Neuromuscular Facilitation for treatment of patients with Traumatic Brachial Plexus Injury

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3yc3bg
Enrollment
Unknown
Registered
2018-10-01
Start date
2018-10-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic Brachial Plexus Injury

Interventions

Experimental Group: 5 adults patients with traumatic upper plexus injury after surgery will recieve physical therapy Protocol of Propriocptive Neuromuscular Facilitation (PNF), twice a week in a perio
Other
E02.779

Sponsors

Universidade Federal de Pernambuco
Lead Sponsor
Universidade Federal de Pernambuco
Collaborator

Eligibility

Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Individuals who suffered traumatic upper brachial plexus injury; both sexes; age between 18 and 40 years; clinical diagnosis according to the routine protocol established at the service and confirmed by electrodiagnostic assessment - Electromyography (EMG) and/or Magnetic Resonance Imaging; who have indication of performing nerve transfer surgery; accompanied in the neurosurgery of peripheral nerves ambulatory at the Hospital da Restauração; with the minimum degree of comprehension necessary to understand the questions of the questionnaires, according to the Mini Mental State Examination (MMSE).

Exclusion criteria

Exclusion criteria: Patients with some type of articular ankylosis (shoulder, elbow, wrist); with incapacitating and uncontrolled neuropathic pain; who have suffered multi-trauma that makes it impossible to perform the positions and exercises of the protocol.

Design outcomes

Primary

MeasureTime frame
Improved functionality, evaluated by the DASH score reduction in the initial, pre-surgical and postoperative evaluation (15 days, 3, 6, 9 and 12 months after).;Perception of patient improvement, assessed by the score obtained from the Patient Global Impression of Change Scale, portuguese version (PGIC - VP), at the end of the intervention.;Improved quality of life, assessed by WHOQOL-BREF brazilian version developed by World Health Organization.

Secondary

MeasureTime frame
Increased range of joint and shoulder motion, assessed by goniometry, data collected in the initial evaluation, preoperative and postoperative (15 days, 3, 6, 9 and 12 months after).;Increased muscle strength of the shoulder and elbow muscles, assessed by the Medical Research Council Manual Test, data collected in the initial evaluation, preoperative and postoperative (15 days, 3, 6, 9 and 12 months after).;Reduction of pain intensity, evaluated by the numerical scale of pain (0 to 10), and absence of neuropathic pain, evaluated by neuropathic pain questionnaire in 4 questions. Data collected in the initial evaluation, preoperative and postoperative (15 days, 3, 6, 9 and 12 months after).;Sensitivity improvement, classified as normal, by evaluation in the areas of the corresponding C5 and C6 dermatomes, data collected in the initial evaluation, preoperative and postoperative (15 days, 3, 6, 9 and 12 months after).

Countries

Brazil

Contacts

Public ContactDaniella de Oliveira

Universidade Federal de Pernambuco

sabinodaniellaufpe@gmail.com+55 81 2126-7961

Outcome results

None listed

Source: REBEC (via WHO ICTRP)